Skip to content

Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity

Double Blind Placebo Controlled Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05882084
Enrollment
24
Registered
2023-05-31
Start date
2023-07-24
Completion date
2023-12-31
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Photoaging

Keywords

Carotenoid, Astaxanthin, Skin, Hydration, Elasticity

Brief summary

This study is a double-blind placebo controlled study to assess whether oral astaxanthin can improve skin hydration, skin elasticity, improve skin pigmentation, and reduce facial redness.

Interventions

DIETARY_SUPPLEMENTAstaxanthin 6 mg daily

Astaxanthin at 6 mg is given for daily ingestion and compared against placebo.

DIETARY_SUPPLEMENTPlacebo

Placebo

Sponsors

AstaReal
CollaboratorUNKNOWN
Integrative Skin Science and Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Astaxanthin vs Placebo

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Females who are 30 to 55 years of age * Half of the women will have Fitzpatrick skin type 1-3 and the other half of the women will have Fitzpatrick skin type 4-6

Exclusion criteria

* Individuals with a known allergy to astaxanthin or other carotenoids (such as zeaxanthin, lutein, lycopene). * Individuals who are unwilling to discontinue carotenoid supplementation for at least 1 month prior to enrollment * Individuals unwilling to restrict intake of foods like shrimp, salmon, mangos, carrots, and tomatoes during the study. * New supplementation within 4 weeks with tocopherol * Individuals who are unwilling to stay consistent with a facial cleansing regimen. * Those who are unwilling to discontinue topical hydroquinone, retinoid or benzoyl peroxide for 2 weeks prior to enrollment * Individuals who are pregnant or breastfeeding. * Individuals who have changed any of their hormonal based contraception within 3 months prior to joining the study. * Current tobacco smoker or a tobacco smoking history of greater than 10 pack-years

Design outcomes

Primary

MeasureTime frameDescription
Skin Hydration8 weeksSkin hydration measured with a non-invasive device, SkinMoistureMeterSC
Skin elasticity8 weeksSkin elasticity measured with a non-invasive device, Skin Elastimeter

Secondary

MeasureTime frameDescription
Facial pigmentation8 weeksFacial pigment as measured by BTBP facial imaging analysis
Facial redness8 weeksFacial pigment as measured by BTBP facial imaging analysis

Countries

United States

Contacts

Primary ContactRaja Sivamani, MD
research@integrativeskinresearch.com916-524-1216

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026